HomeCompareWKSPW vs PFE

WKSPW vs PFE: Dividend Comparison 2026

WKSPW yields 7692.31% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WKSPW wins by $4177739098279589.00M in total portfolio value
10 years
WKSPW
WKSPW
● Live price
7692.31%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4177739098279589.00M
Annual income
$4,073,565,928,588,968,500,000.00
Full WKSPW calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — WKSPW vs PFE

📍 WKSPW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWKSPWPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WKSPW + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WKSPW pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WKSPW
Annual income on $10K today (after 15% tax)
$653,846.15/yr
After 10yr DRIP, annual income (after tax)
$3,462,531,039,300,623,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, WKSPW beats the other by $3,462,531,039,300,623,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WKSPW + PFE for your $10,000?

WKSPW: 50%PFE: 50%
100% PFE50/50100% WKSPW
Portfolio after 10yr
$2088869549139794.50M
Annual income
$2,036,782,964,294,484,200,000.00/yr
Blended yield
97.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

WKSPW
No analyst data
Altman Z
0.0
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WKSPW buys
0
PFE buys
0
No recent congressional trades found for WKSPW or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWKSPWPFE
Forward yield7692.31%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4177739098279589.00M$49.6K
Annual income after 10y$4,073,565,928,588,968,500,000.00$26,258.71
Total dividends collected$4170772265337663.00M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WKSPW vs PFE ($10,000, DRIP)

YearWKSPW PortfolioWKSPW Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$779,931$769,230.77$9,153$693.39+$770.8KWKSPW
2$56,904,315$56,069,789.30$8,593$849.25+$56.90MWKSPW
3$3,884,151,673$3,823,264,055.84$8,336$1,066.78+$3884.14MWKSPW
4$248,050,254,929$243,894,212,638.74$8,437$1,384.80+$248050.25MWKSPW
5$14,822,056,221,428$14,556,642,448,653.80$9,013$1,875.40+$14822056.21MWKSPW
6$828,776,618,419,079$812,917,018,262,150.50$10,306$2,680.72+$828776618.41MWKSPW
7$43,367,472,132,823,630$42,480,681,151,115,220.00$12,820$4,101.38+$43367472132.81MWKSPW
8$2,123,871,047,251,591,000$2,077,467,852,069,469,400.00$17,673$6,826.70+$2123871047251.57MWKSPW
9$97,358,102,514,598,310,000$95,085,560,494,039,100,000.00$27,543$12,591.86+$97358102514598.28MWKSPW
10$4,177,739,098,279,589,000,000$4,073,565,928,588,968,500,000.00$49,560$26,258.71+$4177739098279589.00MWKSPW

WKSPW vs PFE: Complete Analysis 2026

WKSPWStock

Worksport Ltd., through its subsidiary, designs and distributes truck tonneau covers in Canada and the United States. The company offers soft tonneau covers, such as vinyl wrapped tri- and quad-fold tonneau covers; and hard tonneau covers, including tri- and quad-fold, aluminum flush-mounted, and top-mounted folding tonneau covers. It also offers Worksport SOLIS, a tonneau cover with integrated solar panels; and Worksport COR energy storage system, a modular, portable power station. The company also sells its products through online retail channels. The company was formerly known as Franchise Holdings International, Inc. and changed its name to Worksport Ltd. in May 2020. Worksport Ltd. is based in West Seneca, New York.

Full WKSPW Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this WKSPW vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WKSPW vs SCHDWKSPW vs JEPIWKSPW vs OWKSPW vs KOWKSPW vs MAINWKSPW vs JNJWKSPW vs MRKWKSPW vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.